Regulatory News
Position ：
- Ganagliflozin Proline Tablets approved for marketing by China NMPA2024-02-22
- Lecanemab Injection approved for marketing by China NMPA2024-01-31
- FDA Approves First Gene Therapies to Treat Patients with Sickle Cell Disease2024-01-24
- Innovative TCM Ercha Shangqing Wan approved for marketing by China NMPA2024-01-17
- Atilotrelvir Tablets/Ritonavir Tablets (co-packaged) approved with conditions for marketin...2024-01-04
- Dimdazenil Capsules approved for marketing by China NMPA2024-01-04
- Vebreltinib Enteric Capsules approved with conditions for marketing by China NMPA2023-12-22
- Xianglei Tangzu Cream approved with conditions for marketing by China NMPA2023-12-22
- Major progress in drug review and evaluation in 20222023-11-15
- Aponermin for Injection approved for marketing by China NMPA2023-11-14